// COMPANY
Avoro Ventures
SECTOR VENTURE CAPITALMENTIONS 1LAST SEEN JULY 21, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Lucinda Shen·JULY 21, 2026
“Scribe Therapeutics...plans to raise up to $108m in an IPO...It's raised $121m from a16z, Avoro Ventures, Eli Lilly, OrbiMed, T. Rowe Price, Perceptive Advisors, Wellington Management, RA Capital Management, and Menlo Ventures.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.